Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Devoogdt

Showing results (61-70 of 153) with videos related to

Pageof 16
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CTIlse Vaneycken, Jochen Govaert, Cécile Vincke, et al.
ACS Nano|May 26, 2011
Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapyBieke Van de Broek, Nick Devoogdt, Antoine D'Hollander, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2010
Nanobodies as tools for in vivo imaging of specific immune cell typesKurt De Groeve, Nick Deschacht, Celine De Koninck, et al.
Expert Opinion on Investigational Drugs|August 28, 2023
Current status and future expectations of nanobodies in oncology trialsTessa De Pauw, Lynn De Mey, Jens M Debacker, et al.
Molecular Imaging and Biology|September 7, 2017
Evaluation of [<sup>99m</sup>Tc]Radiolabeled Macrophage Mannose Receptor-Specific Nanobodies for Targeting of Atherosclerotic Lesions in MiceGezim Bala, Henri Baudhuin, Isabel Remory, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 14, 2012
Molecular imaging using Nanobodies: a case studyNick Devoogdt, Catarina Xavier, Sophie Hernot, et al.
Molecular Cancer Therapeutics|October 22, 2017
Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin LymphomaAhmet Krasniqi, Matthias D'Huyvetter, Catarina Xavier, et al.
Experimental Hematology & Oncology|October 4, 2024
AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategiesNiels Vandewalle, Nathan De Beule, Ann De Becker, et al.
Molecular Imaging and Biology|April 15, 2017
Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical EvaluationZhengyuan Zhou, Ganesan Vaidyanathan, Darryl McDougald, et al.
Frontiers in Immunology|March 11, 2021
Development and Characterization of Nanobodies Targeting the Kupffer CellFang Zheng, Jinhong Zhou, Zhenlin Ouyang, et al.
Pageof 16

Showing results (61-70 of 153) with videos related to

Sort By:
Pageof 16
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CTIlse Vaneycken, Jochen Govaert, Cécile Vincke, et al.
ACS Nano|May 26, 2011
Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapyBieke Van de Broek, Nick Devoogdt, Antoine D'Hollander, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2010
Nanobodies as tools for in vivo imaging of specific immune cell typesKurt De Groeve, Nick Deschacht, Celine De Koninck, et al.
Expert Opinion on Investigational Drugs|August 28, 2023
Current status and future expectations of nanobodies in oncology trialsTessa De Pauw, Lynn De Mey, Jens M Debacker, et al.
Molecular Imaging and Biology|September 7, 2017
Evaluation of [<sup>99m</sup>Tc]Radiolabeled Macrophage Mannose Receptor-Specific Nanobodies for Targeting of Atherosclerotic Lesions in MiceGezim Bala, Henri Baudhuin, Isabel Remory, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 14, 2012
Molecular imaging using Nanobodies: a case studyNick Devoogdt, Catarina Xavier, Sophie Hernot, et al.
Molecular Cancer Therapeutics|October 22, 2017
Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin LymphomaAhmet Krasniqi, Matthias D'Huyvetter, Catarina Xavier, et al.
Experimental Hematology & Oncology|October 4, 2024
AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategiesNiels Vandewalle, Nathan De Beule, Ann De Becker, et al.
Molecular Imaging and Biology|April 15, 2017
Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical EvaluationZhengyuan Zhou, Ganesan Vaidyanathan, Darryl McDougald, et al.
Frontiers in Immunology|March 11, 2021
Development and Characterization of Nanobodies Targeting the Kupffer CellFang Zheng, Jinhong Zhou, Zhenlin Ouyang, et al.
Pageof 16